LAUPPE, Rosa; NILSSON, Fredrik O. L.; FUES WAHL, Hanna; LILJA, Mathias; VIKSTRÖM, Anders; ASANIN, Sandra T. Use of ALK-tyrosine kinase inhibitors (ALK TKI) in clinical practice, overall survival, and treatment duration – a Swedish nationwide retrospective study. Acta Oncologica, [S. l.], v. 61, n. 11, p. 1354–1361, 2022. DOI: 10.1080/0284186X.2022.2133972. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/23842. Acesso em: 18 jun. 2026.